Example Email Digest


            
              5 of 43 brands require attention this week
            

            
      
        Jublia At Risk
        Highest risk: Visual Distraction · FDA letter on file
      
      54
    

      
        Sotyktu At Risk
        Highest risk: Visual Distraction 
      
      54
    

      
        Fasenra At Risk
        Highest risk: Visual Distraction · FDA letter on file
      
      57
    

      
        Velsipity At Risk
        Highest risk: Visual Distraction · FDA letter on file
      
      58
    

      
        BRUKINSA At Risk
        Highest risk: Visual Distraction · FDA letter on file
      
      58
    

            
              Algorithm Update
              New FDA enforcement letter incorporated (Apr 28, 2026: NUBEQA). 0 violation patterns detected.
            

            View Full Dashboard

            
              You're receiving this because you're subscribed to Video Content Compliance Monitor alerts.
              Manage preferences

Example Email Digest

Weekly Compliance Digest

Jublia At Risk

Sotyktu At Risk

Fasenra At Risk

Velsipity At Risk

BRUKINSA At Risk

Algorithm Update

Weekly Compliance Digest